Is There a Blood Test for Liver Cancer? (Yes — Here's How to Get One at Home)
Is There a Blood Test for Liver Cancer? (Yes — Here’s How to Get One at Home)
Yes. Blood tests can help detect liver cancer. The AFP test measures a protein that may rise when cancer is present. Newer liquid biopsy and ctDNA tests identify cancer-associated biomarkers in the bloodstream — sometimes before symptoms appear. MoleculeDx offers an at-home Fusion-detect™ test with 95% accuracy for people at higher risk.
What Types of Blood Tests Detect Liver Cancer?
AFP Test measures alpha-fetoprotein in your blood — the most widely used liver cancer screening marker.
Liquid Biopsy detects cancer-associated biomarkers in your bloodstream and is available through at-home kits.
ctDNA Testing identifies tumor DNA fragments in the blood — a fast-growing area of cancer detection.
Most doctors combine more than one test along with imaging for the most accurate results.
What Is an AFP Test?
AFP is a protein naturally produced during fetal development. In healthy adults it stays very low. Normal levels are below 10 ng/mL. Levels above 400 ng/mL in someone with a liver mass are a serious warning sign for liver cancer. AFP can also rise from cirrhosis or hepatitis — so a high result means further testing is needed, not that cancer is confirmed. AASLD guidelines recommend AFP testing combined with ultrasound every six months for high-risk patients.
How Accurate Are These Tests?
Standard AFP testing alone detects only around 40–60% of early liver cancers — meaning a significant number of cases are missed. Some cancers are AFP-negative and never trigger elevated levels. Liquid biopsy and ctDNA testing scan for broader cancer signals and can improve early detection. No single test replaces physician evaluation or imaging — used together they give a more complete picture.
What Is MoleculeDx and How Does It Work?
MoleculeDx is a molecular diagnostics company focused on accessible, early liver cancer detection. Their proprietary Fusion-detect™ platform uses AI-powered genomic sequencing to identify liver cancer fusion gene biomarkers in a standard blood sample — biomarkers that conventional AFP tests are unable to detect.
The Fusion-detect™ test achieves 95% overall accuracy (94.2% sensitivity, 95% specificity), compared to approximately 52% for standard AFP testing alone. The technology has been trained on more than 50,000 patient samples across four AI model generations since 2014, and is validated by a CLIA-certified lab.
A certified phlebotomist visits your home, collects a blood sample in under 10 minutes, and results are delivered digitally within 24 hours — with no hospital visit, biopsy, or specialist referral required.
Can I Take a Liver Cancer Blood Test at Home?
Yes. MoleculeDx offers at-home collection through its network of certified phlebotomy partners (Portamedic and Travalab) — a trained professional comes to your door, usually within 48 hours of booking. This is especially helpful for high-risk patients in rural areas or with limited mobility. Early detection significantly improves survival outcomes.
Take Control of Your Liver Health
If you have hepatitis, cirrhosis, fatty liver disease, or a family history of liver cancer, blood-based screening may help detect cancer signals earlier.
Learn About MoleculeDx Testing →
What Happens After a Positive Result?
A high result does not mean you have cancer. Your doctor will review your history and order imaging — ultrasound, MRI, or CT scan. A biopsy is only done when imaging finds a suspicious mass and diagnosis remains unclear.
How Much Does It Cost?
AFP testing is often covered by insurance for high-risk patients. MoleculeDx is currently in active partnership discussions with major insurers including UnitedHealth Group, Anthem/Blue Cross, Aetna, Cigna, and Humana — and their patient support team will verify your coverage for free before you book. Without insurance coverage, the MoleculeDx Standard Package is $160. Visit moleculedx.com or book directly at booking.moleculedx.com.
Frequently Asked Questions
What blood test detects liver cancer?
The AFP test is most common but only detects 40–60% of early cases. MoleculeDx’s Fusion-detect™ achieves 95% accuracy and catches biomarkers AFP misses.
What is an AFP test?
It measures alpha-fetoprotein in your blood. Normal is below 10 ng/mL. Above 400 ng/mL may indicate liver cancer.
Can liver cancer be found before symptoms?
Yes. Fusion-detect™ can detect biomarkers up to 18 months before imaging-detectable tumors.
Can I test at home?
Yes. MoleculeDx sends a certified phlebotomist to your door within 48 hours. Results in 24 hours.
What symptoms mean I should get tested?
Weight loss, abdominal pain, jaundice, fatigue — or any history of hepatitis, cirrhosis, or fatty liver disease.
Does high AFP always mean cancer?
No. Cirrhosis and hepatitis can also raise AFP. Further evaluation is always needed.
Read more about: https://www.moleculedx.com/liver-cancer-blood-test/
